<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Agencies of the European Union / Clinical pharmacology / Drugs / Drug safety / European Medicines Agency / Heads of Medicines Agencies / Pharmacovigilance / Prescription drug / Adverse effect / European Federation of Pharmaceutical Industries and Associations / Pharmaceutical drug
Pharmaceuticals policy
Agencies of the European Union
Clinical pharmacology
Drugs
Drug safety
European Medicines Agency
Heads of Medicines Agencies
Pharmacovigilance
Prescription drug
Adverse effect
European Federation of Pharmaceutical Industries and Associations
Pharmaceutical drug

AESGP AmsterdamFebruaryConference report

Add to Reading List

Source URL: www.aesgp.eu

Download Document from Source Website

File Size: 3,25 MB

Share Document on Facebook

Similar Documents

Web-Scale Pharmacovigilance: Listening to Signals from the Crowd Ryen W. White Ph.D.1*, Nicholas P. Tatonetti Ph.D.2, Nigam H. Shah M.B.B.S. Ph.D.3, Russ B. Altman M.D. Ph.D.4 and Eric Horvitz M.D. Ph.D.1 1 Microsoft Re

DocID: 1vpEW - View Document

Centre Anti Poison et de Pharmacovigilance du Maroc Société Marocaine de Toxicologie

DocID: 1v4Ie - View Document

Microsoft Word - Simple guide to Veterinary Pharmacovigilance in the EU

DocID: 1uY7F - View Document

PREPARATION D’UN DIPLOME DE TOXICOLOGIE - PHARMACOVIGILANCE   

DocID: 1uOXD - View Document

Liste des inscrits à la formation de toxicologie pharmacovigilance Année 2005 – 2006 Module « Pharmacovigilance » Nom Abouali Fatima Achour Sanaa

DocID: 1uKFW - View Document